Topic Archives: Atheronova (AHRO)

April 5, 2014 / DrKSSMDPhD

Another Hot Australian Biotech: Is Biotron Right for Your Portfolio?

[Ed. Note: Here is our second installment from Dr. KSS, formerly known as “karmaswimswami” in Gumshoe discussion threads. Dr. KSS has agreed to our trading and disclosure restrictions, and he’s not offering you personal investment or medical advice. As with all of our columnists, we don’t assign topics or opinions and do just a bit of light […]

1,174 Comments Read More

March 10, 2014 / DrKSSMDPhD

NASH: An All-Too-Common Liver Disease and a Company Aiming to Treat It

Introducing Dr. KSS, our newest columnist (formerly known as karmaswimswami)

1,456 Comments Read More

Comments

written by reader

Payola from Portola? / Nov 30, 9:20pm

This reminds me of Atheronova ($AHRO). It is now at $0.36 cents a share. The SP of $1.68 went over a waterfall when they...

jer_vic on written by reader

written by reader

Another Hot Australian Biotech: Is Biotron Right for Your Portfolio? / Apr 17, 2:51pm

Atheronova (AHRO) update: There was a shareholder meeting yesterday, and here are some UNCORROBORATED information. It w...

jer_vic on written by reader

written by reader

Another Hot Australian Biotech: Is Biotron Right for Your Portfolio? / Apr 9, 4:43pm

Atheronova (AHRO) update.Dr. KSS your theory about doing the trials in Russia (post #129) may hold water: https://...

jer_vic on written by reader

written by reader

NASH: An All-Too-Common Liver Disease and a Company Aiming to Treat It / Apr 6, 12:08am

I volunteer for: Atheronova (AHRO) and Patrys Ltd. (PAB/PATZF)....

karmaswimswami on “This Tiny, Unknown Biotech is About to Unleash Its ‘Holy Grail’ Drug” / Jan 19, 5:13pm

I am putting AtheroNova (AHRO) back on a watch list. I was not so favorable on it earlier, but I am reconsidering. Here'...